Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders characterized by chronic relapsing inflammation of the gastrointestinal tract that affect 0.1% of Western populations, comprising two major forms, Crohn's disease (CD) and ulcerative colitis (UC). Adjuvants to the traditional therapy of inflammatory bowel disease (IBD) have been studied to enhance the efficacy of the treatment and improve patients’ quality of life. Approximately 1.6 million Americans currently have IBD, a growth of about 200,000 since the last time CCFA reported in 2011. As many as 70,000 new cases of IBD are diagnosed in the United States each year. There may be as many as 80,000 children in the United States with IBD. 

    Related Conference of Inflammatory Bowel Diseases

    March 10-11, 2025

    8th International Congress on Viral Hepatitis

    Paris, France
    March 13-14, 2025

    13th International Conference on Gynecology and Obstetrics

    Prague, Czech Republic
    July 07-08, 2025

    20th Euro-Global Gastroenterology Conference

    Zurich, Switzerland

    Inflammatory Bowel Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in